Welcome to our dedicated page for Hsbc Holdings Plc SEC filings (Ticker: HSBC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The HSBC Holdings plc (HSBC) SEC filings page provides access to the company’s regulatory disclosures as a foreign private issuer. HSBC files annual reports on Form 20‑F and frequent current reports on Form 6‑K, which together give investors detailed information about its global banking and financial services operations, capital structure, governance, and risk profile.
Form 6‑K filings for HSBC include a variety of disclosures, such as dividend announcements, voting rights and capital updates, board and senior management changes, and information on regulatory matters like Bank of England bank capital stress test results. Other 6‑K submissions cover employee share and incentive plans, including block listing six‑monthly returns and grants of conditional awards under the HSBC International Employee Share Purchase Plan and other share plans.
Filings also document transactions by persons discharging managerial responsibilities (PDMRs), where HSBC reports acquisitions of ordinary shares through dividend reinvestment or other mechanisms, in line with market abuse regulations. In addition, HSBC uses SEC filings to communicate significant group developments, such as joint announcements related to the proposed privatization of Hang Seng Bank Limited and associated listing withdrawal processes.
On Stock Titan, these filings are updated in near real time from the SEC’s EDGAR system. AI‑powered summaries help explain the content of lengthy documents, highlighting key points from annual reports (Form 20‑F), interim updates, dividend declarations, capital and voting rights notices, and share plan disclosures. Investors can quickly see what has changed, how board and governance announcements may affect oversight, and how share‑based compensation plans impact potential dilution.
Users interested in insider‑related activity can review PDMR transaction notices, while those focused on earnings, capital, and risk can turn to dividend and stress test‑related filings. Together, these documents form an official record of HSBC’s regulatory communications, supporting deeper analysis of HSBC stock.
HSBC Holdings plc will recognise a US$1.1bn provision in Q3 2025 following developments in the Herald Fund SPC litigation related to the Madoff fraud. The Luxembourg Court of Cassation denied HSSL’s appeal on Herald’s securities restitution claim and accepted HSSL’s appeal on the cash restitution claim; HSSL will pursue a second appeal before the Court of Appeal.
The provision is expected to have an around 15 bps impact on the Group’s CET1 capital ratio. It will be classified as a material notable item and will not impact FY25 RoTE excluding notable items or any dividend. HSBC plans to announce its Q3 2025 results on 28 October 2025.
HSBC Holdings plc reported the conclusion of its share buy-back programme. On 24 October 2025, the company purchased 1,297,200 ordinary shares on the Hong Kong Stock Exchange at a volume-weighted average price of HK$103.2808 (highest HK$103.5000, lowest HK$102.9000).
Since commencement, HSBC repurchased for cancellation 136,301,568 ordinary shares on UK venues at a VWAP of £9.8038 per share and 91,040,400 ordinary shares on the Hong Kong Stock Exchange at a VWAP of HK$102.5661 per share, for total consideration of approximately US$3bn.
Following cancellation of shares repurchased on UK venues, issued ordinary share capital consists of 17,201,971,220 shares with voting rights; there are no treasury shares. Cancellation of Hong Kong repurchases takes longer, and a further total voting rights announcement will follow once completed.
HSBC Holdings plc repurchased 800 ordinary shares on the Hong Kong Stock Exchange on 21 October 2025 at HK$102.1000 per share as part of its buy-back announced on 31 July 2025.
Since the programme began, HSBC has repurchased 226,044,768 ordinary shares for a total consideration of approximately US$2,976.8m. There were no repurchases on the London Stock Exchange, Aquis, Cboe Europe (BXE/CXE), or Turquoise on this date.
Following cancellation of shares repurchased on UK venues, the issued ordinary share capital will consist of 17,201,971,220 ordinary shares with voting rights, and there are no ordinary shares held in treasury. Cancellation of Hong Kong Stock Exchange repurchases takes longer, and a further announcement of total voting rights will be made once those shares have been cancelled.
HSBC Holdings plc repurchased and cancelled its own shares as part of the buy-back announced on 31 July 2025. On 17 October 2025, the Company bought 4,942,855 ordinary shares on UK venues at a volume‑weighted average price of £9.7082 (range: £9.6410–£9.7900) and 4,566,400 ordinary shares on the Hong Kong Stock Exchange at a volume‑weighted average price of HK$101.6150 (range: HK$100.6000–HK$102.4000).
Since the programme began, HSBC has repurchased 226,043,968 ordinary shares for total consideration of approximately US$2,976.7m. Following cancellation of the UK‑venue shares, issued ordinary share capital will consist of 17,201,971,220 shares with voting rights; there are no treasury shares. Cancellation of Hong Kong repurchases will be announced once completed.
HSBC Holdings plc reported share repurchases on 16 October 2025 under its ongoing buy-back. The company bought 7,736,486 ordinary shares on UK venues at a volume-weighted average price of £9.8750, and 2,094,800 shares on the Hong Kong Stock Exchange at a volume-weighted average price of HK$102.2585.
Since the buy-back began on 31 July 2025, HSBC has repurchased 216,534,713 ordinary shares for total consideration of approximately US$2,852.6m.
Following cancellation of the shares repurchased on UK venues, issued ordinary share capital will consist of 17,206,914,075 shares with voting rights. There are no ordinary shares held in treasury. Cancellation of Hong Kong repurchases takes longer, and a further total voting rights announcement will follow once those shares have been cancelled.
HSBC Holdings plc announced that a committee of its Board will meet on 28 October 2025 to consider releasing the Earnings Release for the Third Quarter 2025 and the payment of a third interim dividend for 2025 on the ordinary shares.
Subject to approval and confirmation at the Board Meeting, the dividend would be payable on 18 December 2025 to holders of record on 7 November 2025. Eligibility spans the UK Principal register, the Hong Kong and Bermuda Overseas Branch registers, and American Depositary Share holders in New York. Further details will be included in the Results announcement if approved.
HSBC Holdings plc is exercising its option to redeem in full two note series due in 2026: the GBP1,000,000,000 Series 33 Resettable Notes and the EUR1,000,000,000 Series 40 Fixed-to-Floating Notes. Both series will be redeemed at their respective par Calculation Amounts together with accrued but unpaid interest from 13 November 2024 to (but excluding) the redemption date of 13 November 2025. The notices state that repayment will be made via the relevant clearing systems and that listing and admission to trading on the FCA Official List and the London Stock Exchange Main Market will be cancelled on or shortly after 14 November 2025.
HSBC Holdings plc reports continued execution of its buy-back program announced 31 July 2025. Since the program began the company has repurchased 141,893,574 ordinary shares for approximately US$1,842.1m. On 23 September 2025 HSBC purchased and cancelled 2,154,763 shares on UK venues at an average price of £10.3854 and 1,471,200 shares on the Hong Kong Stock Exchange at an average price of HK$108.0431. After cancelling the UK repurchases the issued share capital is 17,279,597,298 ordinary shares, which shareholders should use as the denominator for disclosure calculations. Cancellation of the Hong Kong trades is pending and will be reflected in a later announcement.
HSBC Holdings plc reports share repurchases made under its buy-back announced 31 July 2025. On 22 September 2025 the Company bought for cancellation 2,182,488 ordinary shares on UK Venues at prices shown (£10.3160 high, £10.2160 low, average £10.2779) and 1,490,000 ordinary shares on the Hong Kong Stock Exchange at prices shown (HK$107.2000 high, HK$106.4000 low, average HK$106.9222). Since the buy-back began the Company has repurchased 138,267,611 ordinary shares for approximately US$1,791.5 million in total. After cancelling the UK Venues purchases, issued ordinary share capital will be 17,281,752,061 voting shares and there are no shares held in treasury. The Company notes that cancellation of Hong Kong-repurchased shares takes longer and will be reflected in a later announcement. A full breakdown of Merrill Lynch's trades on behalf of HSBC is available via the provided RNS link.
HSBC Holdings plc announced it purchased for cancellation additional ordinary shares as part of its buy-back launched 31 July 2025. On 19 September 2025 the company repurchased 2,149,715 shares on UK venues at an average price of £10.2427 per share and 1,490,000 shares on the Hong Kong Stock Exchange at an average price of HK$106.5533 per share. Since the buy-back began the company has repurchased 134,595,123 ordinary shares for total consideration of approximately US$1,740.7 million. Following cancellation of the UK-venue repurchases, issued ordinary share capital is 17,283,934,549 shares, which shareholders may use as the denominator for disclosure calculations. A full trade breakdown is available via the provided RNS link.